CLAIRE CAYER: Open Payments
NPI 1720004476 · NEW BEDFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 33 payments from 4 companies in 2025. Trend: 2023 $693 · 2024 $648 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 17 | $383 |
| Otsuka America Pharmaceutical, Inc. | 12 | $273 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
Products named: REXULTI, INGREZZA, CAPLYTA.
Industry payments across MA — which companies pay providers there.
